Development of a quantitative bioassay to assess preventive compounds against inflammation-based carcinogenesis

Nitric Oxide - Biology and Chemistry

Volumn 25, Issue 2, 2011, Pages 183-194

  Onuma, Kunishige ^a   Suenaga, Yuka ^b   Sakaki, Ryuta ^b   Yoshitome, Satoshi ^b   Sato, Yu ^c   Ogawara, Satomi ^c   Suzuki, Saori ^c   Kuramitsu, Yasuhiro ^d   Yokoyama, Hidekatsu ^e   Murakami, Akira ^f   Hamada, Junichi ^g   Nicolson, Garth L ^h   Kobayashi, Masanobu ⁱ   Fujii, Junichi ^c   Okada, Futoshi ^b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

^d YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^f KYOTO UNIVERSITY   (Japan)

^g HOKKAIDO UNIVERSITY   (Japan)

^h Institute for Molecular Medicine   (United States)

ⁱ HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Inflammation related carcinogenesis; Inflammatory cell attachment; Nitric oxide; Oxygen radicals

Indexed keywords

8 HYDROXY 2' DEOXYGUANINE; ALPHA TURMERONE; ARTURMERONE; AURAPTENE; BETA ATLANTONE; BETA TURMERONE; GELATIN SPONGE; GERMACRONE; GUANINE DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; TURMERONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; BIOASSAY; CARCINOGENESIS; CELL INFILTRATION; CONFERENCE PAPER; DRUG MECHANISM; ENDOTHELIUM CELL; FLUORESCENCE; FOREIGN BODY; INFLAMMATION; INFLAMMATION RELATED CARCINOGENESIS; INFLAMMATORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTICARCINOGENIC AGENTS; BIOLOGICAL ASSAY; CELL ADHESION; COUMARINS; ENDOTHELIAL CELLS; FEMALE; FIBROSARCOMA; FLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KETONES; METHYLCHOLANTHRENE; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; PLANT OILS; TOLUENE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 80051548751     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2011.02.003     Document Type: Conference Paper

References (59)

1. R.A. Weinberg, in: The Biology of Cancer Garland Science, Taylor & Francis Group, New York, NY, USA, 2007, pp.454-457.
2. H. zur Hausen The search for infectious causes of human cancers: Where and why Virology 392 2009 1 10
3. D.M. Parkin, The global health burden of infection-associated cancers in the year 2002, Int. J. Cancer 118 (2006) 3030-3044.
4. A.N. Burnett-Hartman, P.A. Newcomb, and J.D. Potter Infectious agents colorectal cancer: a review Helicobacter pylori Streptococcus bovis JC virus and human papillomavirus Cancer Epidemiol. Biomarkers. Prev. 17 2008 2970 2979
5. L. Steinman Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab Nat. Rev. Drug Discov. 4 2005 510 518 (Pubitemid 40861993)
6. R.E. Harris Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer Subcell. Biochem. 42 2007 93 126
7. F.M. Giardiello, S.R. Hamilton, A.J. Krush, S. Piantadosi, L.M. Hylind, P. Celano, S.V. Booker, C.R. Robinson, and G.J. Offerhaus Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis N. Eng. J. Med. 328 1993 1313 1316 (Pubitemid 23131373)
8. L.A.G. Rodriguez, and S. Hernandez-Diaz Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure Epidemiology 14 2003 240 246 (Pubitemid 40417113)
9. E. Half, and N. Arber Colon cancer: preventive agents and the present status of chemoprevention Expert Opin. Pharma-cother. 10 2009 211 219
10. A. Murakami, W. Kuki, Y. Takahashi, H. Yonei, Y. Nakamura, Y. Ohto, H. Ohigashi, and K. Koshimizu Auraptene a citrus coumarin inhibits 12-O-tetra-decanoylphorbol-13-acetate-induced tumor promotion in ICR mouse skin possibly through suppression of superoxide generation in leukocytes Jpn. J. Cancer Res. 88 1997 443 452 (Pubitemid 27267606)
11. K. Sakata, A. Hara, Y. Hirose, Y. Yamada, T. Kuno, M. Katayama, K. Yoshida, Q. Zheng, A. Murakami, H. Ohigashi, K. Ikemoto, K. Koshimizu, T. Tanaka, and H. Mori Dietary supplementation of the citrus antioxidant auraptene inhibits N-N-diethylnitrosamine-induced rat hepatocarcinogenesis Oncology 66 2004 244 252 (Pubitemid 38813052)
12. M. Ishikawa, F. Okada, J. Hamada, M. Hosokawa, and H. Kobayashi Changes in the tumorigenic and metastatic properties of tumor cells treated with quercetin or 5-azacytidine Int. J. Cancer 39 1987 338 342 (Pubitemid 17038188)
13. P.N. Belloni, D.H. Carney, and G.L. Nicolson Organ-derived microvessel endothelial cells exhibit differential responsiveness to thrombin and other growth factors Microvasc. Res. 43 1992 20 45
14. F. Okada, M. Hosokawa, J. Hamada, J. Hasegawa, M. Kato, M. Mizutani, J. Ren, N. Takeichi, and H. Kobayashi Malignant progression of a mouse fibrosarcoma by host cells reactive to a foreign body (gelatin sponge) Br. J. Cancer 66 1992 635 639
15. Y. Iuchi, D. Roy, F. Okada, N. Kibe, S. Tsunoda, S. Suzuki, M. Takahashi, H. Yokoyama, J. Yoshitake, S. Kondo, and J. Fujii Spontaneous skin damage and delayed wound healing in SOD1-deficient mice Mol. Cell Biochem. 341 2010 181 194
16. H. Hirata, H. Iwai, and M. Ono Analysis of a flexible surface-coil-type resonator for magnetic resonance measurements Rev. Sci. Instrum. 66 1995 4529 4534
17. H. Yokoyama, M. Tada, T. Sato, H. Ohya, and T. Akatsuka Modified surface-coil-type resonators for EPR measurements of a thin membrane-like sample Appl. Magn. Reson. 24 2003 233 245 (Pubitemid 37386852)
18. F. Díaz-González, I. González-Alvaro, MR. Campanero, F. Mollinedo, MA. del Pozo, C. Muñoz, JP. Pivel, and F. Sánchez-Madrid Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs J. Clin. Invest. 95 1995 1756 1765
19. F. Okada, H. Shionoya, M. Kobayashi, T. Kobayashi, H. Tazawa, K. Onuma, Y. Iuchi, N. Matsubara, T. Ijichi, B. Dugas, and M. Hosokawa Prevention of inflammation-mediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available superoxide dismutase Br. J. Cancer 94 2006 854 862
20. F. Okada Beyond foreign-body-induced carcinogenesis: impact of reactive oxygen species derived from inflammatory cells in tumorigenic conversion and tumor progression Int. J. Cancer 121 2007 2364 2372 (Pubitemid 350022404)
21. F. Okada, M. Hosokawa, J. Hasegawa, M. Ishikawa, I. Chiba, Y. Nakamura, and H. Kobayashi Regression mechanisms of mouse fibrosarcoma cells after in vitro exposure to quercetin: diminution of tumorigenicity with a corresponding decrease in the production of prostaglandin E2 Cancer Immunol. Immunother. 31 1990 358 364 (Pubitemid 20242561)
22. F. Okada, H. Tazawa, T. Kobayashi, M. Kobayashi, and M. Hosokawa Involvement of reactive nitrogen oxides for acquisition of metastatic properties of benign tumors in a model of inflammation-based tumor progression Nitric Oxide 14 2006 122 129 (Pubitemid 43165877)
23. F. Okada, M. Kobayashi, H. Tanaka, T. Kobayashi, H. Tazawa, Y. Iuchi, K. Onuma, M. Hosokawa, M.C. Dinauer, and N.H. Hunt The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells Am. J. Pathol. 169 2006 294 302
24. H. Yokoyama, Y. Lin, O. Itoh, Y. Ueda, A. Nakajima, T. Ogata, T. Sato, H. Ohya-Nishiguchi, and H. Kamada EPR imaging for in vivo analysis of the half-life of a nitroxide radical in the hippo-campus and cerebral cortex of rats after epileptic seizures Free Radic. Biol. Med. 27 1999 442 448 (Pubitemid 29395439)
25. M. Tada, H. Yokoyama, O. Ito, H. Ohya, and T. Ogata Evaluation of the hepatic reduction of a nitroxide radical in rats receiving ascorbic acid glutathione or ascorbic acid oxidase by in vivo electron spin resonance study J. Gastroenterol. Hepatol. 19 2004 99 105 (Pubitemid 38130614)
26. H.H. Radeke, R.J. Ludwig, and W.-H. Boehncke Experimental approaches to lymphocyte migration in dermatology in vitro and in vivo Exp. Dermatol. 14 2005 641 666 (Pubitemid 41150361)
27. M.A. Lokuta, P.A. Nuzzi, and A. Huttenlocher Calpain regulates neutrophil chemotaxis Proc. Nat. Acad. Sci. USA 100 2003 4006 4011 (Pubitemid 36418147)
28. J.H. Chon, and E.L. Chaikof Soluble heparin-binding peptides regulate chemokinesis and cell adhesive forces Am. J. Physiol. Cell Physiol. 280 2001 C1394 C1402
29. G. Boguslawski, J.R. Grogg, K.A. Harvey, and D. English Use of DAPI staining for quantitation of cell chemotaxis Biotechniques 30 2001 48
30. W.A. Muller, and S.A. Weigl Monocyte-selective transendothelial migration: dissection of the binding and transmigration phases by an in vitro assay J. Exp. Med. 176 1992 819 828
31. R.C. Fuhlbrigge, S.L. King, C.J. Dimitroff, T.S. Kupper, and R. Sackstein Direct real-time observation of E- and P-selectin-mediated rolling on cutaneous lymphocyte-associated antigen immobilized on Western blots J. Immunol. 168 2002 5645 5651 (Pubitemid 34556146)
32. R. Sackstein, J.L. Messina, and G.J. Elfenbein In vitro adherence of lymphocytes to dermal endothelium under shear stress: implications in pathobiology and steroid therapy of acute cutaneous GVHD Blood 101 2003 771 778 (Pubitemid 36077606)
33. G. Cinamon, V. Grabovsky, E. Winter, S. Franitza, S. Feigelson, R. Shamri, O. Dwir, and R. Alon Novel chemokine functions in lymphocyte migration through vascular endothelium under shear flow J. Leukoc. Biol. 69 2001 860 866 (Pubitemid 32577884)
34. T.R. Mempel, S.E. Henrickson, and U.H. von Andrian T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases Nature 427 2004 154 159 (Pubitemid 38094955)
35. C. Kummer, and M.H. Ginsberg New approaches to blockade of alpha4-integrins proven therapeutic targets in chronic inflammation Biochem. Pharmacol. 72 2006 1460 1468 (Pubitemid 44666734)
36. U.H. von Andrian, and C.R. Mackay T cell function migration two sides of the same coin N. Engl. J. Med. 343 2000 1020 1034
37. C.V. Carman Mechanisms for transcellular diapedesis: probing and pathfinding by invadosome-like protrusions J. Cell Sci. 122 2009 3025 3035
38. T. Tanaka, Y. Yasui, R. Ishigamori-Suzuki, and T. Oyama Citrus compounds inhibit inflammation- and obesity-related colon carcinogenesis in mice Nutr. Cancer 60 2008 70 80
39. T. Tanaka, H. Makita, K. Kawabata, H. Mori, M. Kakumoto, K. Satoh, A. Hara, T. Sumida, T. Tanaka, and H. Ogawa Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids diosmin and hesperidin Carcinogenesis 18 1997 957 965 (Pubitemid 28132340)
40. Y.H. Choi, W.H. Lee, K.-Y. Park, and L. Zhang p53-independent induction of p21 (WAF1/CIP1) reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells Jpn. J. Cancer Res. 91 2000 164 173 (Pubitemid 30130746)
41. T. Tanaka, K. Kawabata, M. Kakumoto, K. Matsunaga, H. Mori, A. Murakami, W. Kuki, Y. Takahashi, H. Yonei, K. Satoh, A. Hara, M. Maeda, T. Ota, S. Odashima, K. Koshimizu, and H. Ohigashi Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by citrus auraptene in rats Carcinogenesis 19 1998 425 431 (Pubitemid 28375444)
42. K. Kawabata, T. Tanaka, T. Yamamoto, A. Hara, A. Murakami, K. Koshimizu, H. Ohigashi, G.D. Stoner, and H. Mori Suppression of N-nitrosomethylbenzylamine- induced rat esophageal tumorigenesis by dietary feeding of auraptene J. Exp. Clin. Cancer Res. 19 2000 45 52 (Pubitemid 30305519)
43. P. Krishnan, K.J. Yan, D. Windler, J. Tubbs, R. Grand, B. DLLi, C. Aldaz, J. McLarty, and H. EKleiner-Hancock Citrus auraptene suppresses cyclin D1 and significantly delays N-methyl nitrosourea induced mammary carcinogenesis in female Sprague-Dawley rats BMC Cancer 9 2009 259
44. A. Hara, K. Sakata, Y. Yamada, T. Kuno, N. Kitaori, T. Oyama, Y. Hirose, A. Murakami, T. Tanaka, and H. Mori Suppression of beta-catenin mutation by dietary exposure of auraptene a citrus antioxidant in N,N- diethylnitrosamineinduced hepatocellular carcinomas in rats Oncol. Rep. 14 2005 345 351
45. T. Tanaka, M.B. de Azevedo, N. Durán, J.B. Alderete, F. Epifano, S. Genovese, M. Tanaka, T. Tanaka, and M. Curini Colorectal cancer chemoprevention by two beta-cyclodextrin inclusion compounds of auraptene and 4′-geranyloxyferulic acid Int. J. Cancer 126 2010 830 840
46. H. Kohno, R. Suzuki, M. Curini, F. Epifano, F. Maltese, S.P. Gonzales, and T. Tanaka Dietary administration with prenyloxycoumarins auraptene collinin inhibits colitis-related colon carcinogenesis in mice Int. J. Cancer 118 2006 2936 2942
47. K. Hayashi, R. Suzuki, S. Miyamoto, Y. Shin-ichiroh, H. Kohno, S. Sugie, S. Takashima, and T. Tanaka Citrus auraptene suppresses azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db mice Nutr. Cancer 58 2007 75 84 (Pubitemid 47076165)
48. T. Tanaka, K. Kawabata, M. Kakumoto, H. Makita, A. Hara, H. Mori, K. Satoh, A. Hara, A. Murakami, W. Kuki, Y. Takahashi, H. Yonei, K. Koshimizu, and H. Ohigashi Citrus auraptene inhibits chemically induced colonic aberrant crypt foci in male F344 rats Carcinogenesis 18 1997 2155 2161 (Pubitemid 28134743)
49. T. Tanaka, K. Kawabata, M. Kakumoto, A. Hara, A. Murakami, W. Kuki, Y. Takahashi, H. Yonei, M. Maeda, T. Ota, S. Odashima, T. Yamane, K. Koshimizu, and H. Ohigashi Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes Cancer Res. 58 1998 2550 2556 (Pubitemid 28275424)
50. M. Tang, K. Ogawa, M. Asamoto, N. Hokaiwado, A. Seeni, S. Suzuki, S. Takahashi, T. Tanaka, K. Ichikawa, and T. Shirai Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells Cancer Sci. 98 2007 471 477 (Pubitemid 46566174)
51. K. Kawabata, A. Murakami, and H. Ohigashi Citrus auraptene targets translation of MMP-7 (matrilysin) via ERK1/2-dependent and mTOR-independent mechanism FEBS Lett. 580 2006 5288 5294 (Pubitemid 44415806)
52. T. Tanaka, H. Kohno, M. Murakami, S. Kagami, and K. El-Bayoumy Suppressing effects of dietary supplementation of the organoselenium 1,4-phenylenebis (methylene) Cancer Res. 60 2000 3713 3716
53. M. Curini, F. Epifano, F. Maltese, M.C. Marcotullio, A. Tubaro, G. Altinier, S.P. Gonzales, and J.C. Rodriguez Synthesis and anti-inflammatory activity of natural and semisynthetic geranyloxycoumarins Bioorg. Med. Chem. Lett. 14 2004 2241 2243 (Pubitemid 38481397)
54. A. Murakami, Y. Nakamura, T. Tanaka, K. Kawabata, D. Takahashi, K. Koshimizu, and H. Ohigashi Suppression by citrus auraptene of phorbol ester- and endotoxin-induced inflammatory responses: role of attenuation of leukocyte activation Carcinogenesis 21 2000 1843 1850
55. T. Tanaka, H. Sugiura, R. Inaba, A. Nishikawa, A. Murakami, K. Koshimizu, and H. Ohigashi Immunomodulatory action of citrus auraptene on macrophage functions and cytokine production of lymphocytes in female BALB/c mice Carcinogenesis 20 1999 1471 1476 (Pubitemid 29385432)
56. A. Murakami, W. Kuki, Y. Takahashi, H. Yonei, Y. Nakamura, Y. Ohto, and H. Ohigashi Auraptene a citrus coumarin inhibits 12-Otetradecanoylphorbol-13- acetate-induced tumor promotion in ICR mouse skin possibly through suppression of superoxide generation in leukocytes Jpn. J. Cancer Res. 88 1997 443 452 (Pubitemid 27267606)
57. H. Ohnishi, M. Asamoto, K. Tujimura, N. Hokaiwado, S. Takahashi, K. Ogawa, M. Kuribayashi, T. Ogiso, and H. Okuyama Inhibition of cell proliferation by nobiletin a dietary phytochemical associated with apoptosis characteristic gene expression but lack of effect on early rat hepatocarcinogenesis in vivo Cancer Sci. 95 2004 936 942 (Pubitemid 40089584)
58. T. Tanaka, K. Kawabata, M. Kakumoto, H. Makita, K. Matsunaga, H. Mori, K. Satoh, A. Kara, A. Murakami, K. Koshimizu, and H. Ohigashi Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor 1′-acetoxychavicol acetate Jpn. J. Cancer Res. 88 1997 821 830 (Pubitemid 27475083)
59. W. Kuki, K. Hosotani, H. Ohigashi, and A. Murakami Metabolism and absorption of auraptene (7-geranyloxylcoumarin) in male SD Rats: comparison with 7-ethoxycoumarin Nutr. Cancer 60 2008 368 372 (Pubitemid 351601373)